Xanax Alternatives: Safer Long-Term Options for Anxiety
Clinically reviewed by Daniel Montville, MD
Reviewed November 5, 2026 · Last updated November 5, 2026
Key Takeaways
- Xanax (alprazolam) works quickly, but the FDA warns that physical dependence can develop after several days to weeks of steady use, even as prescribed.
- International treatment guidelines name SSRIs and SNRIs as first-line medications for anxiety disorders and recommend benzodiazepines only when first-line options fail or aren't tolerated.
- First-line alternatives work more slowly. SSRIs and SNRIs usually take 4 to 8 weeks, and buspirone takes 3 to 4 weeks of daily use.
- If you take Xanax now, don't stop suddenly. A 2025 joint guideline recommends starting with dose reductions of 5% to 10% every 2 to 4 weeks, adjusted to how you respond.
Your chest is tight, your thoughts are racing, and you know one small pill could make it stop fast. That pull makes sense once you see what’s happening in your brain. GABA is your nervous system’s main brake, and according to the FDA’s benzodiazepine safety communication, drugs like Xanax bind to GABA receptors and slow brain activity. The calm arrives quickly, but it works through broad sedation rather than precision, and your brain adapts to that extra braking over time.
Benzodiazepines have been FDA-approved since 1960, and alprazolam alone made up 38% of the 92 million benzodiazepine prescriptions dispensed in the U.S. in 2019, according to the same FDA review. The WFSBP anxiety treatment guideline, written by 33 international experts, rates alprazolam as effective for anxiety disorders. The relief is real, and the evidence behind it is solid.
But speed was never the whole goal of anxiety treatment, and at Siggy we’d rather help you feel steady for years than calm for an afternoon.
This guide compares the options that guidelines now put first: SSRIs and SNRIs, buspirone, hydroxyzine, propranolol, and cognitive behavioral therapy. You’ll see how fast each one works, what the research actually shows, and how to come off Xanax safely if you already take it. The first-line options work more slowly than Xanax, but they’re built for long-term use without the same dependence risk.
What This Page Covers
- Why Look for a Xanax Alternative?
- How Do the Alternatives Compare?
- SSRIs and SNRIs: The First-Line Choice
- Buspirone: A Daily Option for Generalized Anxiety
- Hydroxyzine: Short-Term Relief Without a Benzodiazepine
- Propranolol: For the Physical Side of Performance Anxiety
- Where Does Therapy Fit?
- Already Taking Xanax? How to Switch Safely
- Talk Through Your Options at Your Own Pace
Why Look for a Xanax Alternative?
In 2020, the FDA required an updated boxed warning, its most prominent warning, for every benzodiazepine. It covers abuse, misuse, addiction, physical dependence, and withdrawal. The agency notes that physical dependence can develop when benzodiazepines are taken steadily for several days to weeks, even exactly as prescribed, and that combining them with opioids, alcohol, or other sedating drugs raises the risk of overdose and death.
Guidelines have shifted accordingly. The WFSBP guideline recommends benzodiazepines only when first-line treatment with an SSRI or SNRI hasn’t worked or hasn’t been tolerated. It also advises that people with a history of alcohol or substance misuse generally shouldn’t be given them.
None of this means you did something wrong by taking Xanax. It means there are options built for the long run, and you deserve to know them.
How Do the Alternatives Compare?
Each option fills a different role, based on WFSBP, NIMH, FDA, and Cochrane evidence summarized below.
| Option | Typical Role | Main Tradeoff |
|---|---|---|
| Alprazolam (Xanax) | Short-term relief | Dependence and withdrawal risk |
| SSRIs and SNRIs | First-line daily treatment | Usually 4 to 8 weeks to work |
| Buspirone | Daily treatment for generalized anxiety | 3 to 4 weeks, not for as-needed use |
| Hydroxyzine | Short-term anxiety relief | Drowsiness, limited evidence |
| Propranolol | Physical symptoms in performance situations | Weak evidence for anxiety disorders |
SSRIs and SNRIs: The First-Line Choice
The WFSBP guideline names selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) as first-line medications for anxiety disorders. These are daily medications that build their effect gradually rather than sedating you in the moment.
The catch is time. According to NIMH’s medication guide, antidepressants usually take 4 to 8 weeks to work, and sleep, appetite, energy, and concentration often improve before mood lifts. NIMH also notes that for panic disorder and social anxiety, providers typically start with SSRIs or other antidepressants because they have fewer side effects than other medications. Common early side effects include upset stomach, headache, and sexual side effects, which are generally mild and tend to fade.
Those first weeks are when many people give up, often because “no one checks in to see if it’s actually working.” The WFSBP guideline notes that some prescribers briefly pair a benzodiazepine with an SSRI during the first weeks to bridge the gap, which is a decision for your prescriber. Our guides comparing SSRI medications and SNRIs vs. SSRIs go deeper on choosing between them.
Buspirone: A Daily Option for Generalized Anxiety
Buspirone is a non-benzodiazepine medication used for generalized anxiety disorder. A Cochrane buspirone review of 36 trials with 5,908 participants found that buspirone and related drugs worked better than placebo, with about 4 to 5 people needing treatment for one to benefit. The reviewers found it may be somewhat less effective than benzodiazepines, that it seemed most useful for people who hadn’t taken a benzodiazepine before, and that side effects were generally mild.
NIMH adds an important practical detail: buspirone has to be taken every day for 3 to 4 weeks to reach its full effect, and it doesn’t work on an as-needed basis. If you’re used to taking something only on hard days, that’s a real adjustment. Our guide to BuSpar for anxiety covers dosing and side effects.
Hydroxyzine: Short-Term Relief Without a Benzodiazepine
Hydroxyzine is an antihistamine that some prescribers use for anxiety. A Cochrane hydroxyzine review pooled five studies with 884 participants and found it more effective than placebo for generalized anxiety disorder, with efficacy similar to a benzodiazepine and to buspirone. It was linked to more sleepiness than those comparison drugs.
The reviewers were cautious. Because the studies were few, small, and at high risk of bias, they concluded hydroxyzine couldn’t be recommended as a reliable first-line treatment. It can be useful for some people, but it isn’t a direct replacement for a daily first-line medication. Read more in our guide to hydroxyzine for anxiety.
Propranolol: For the Physical Side of Performance Anxiety
Propranolol is a beta-blocker, a type of heart medication. NIMH notes that providers sometimes prescribe beta-blockers off-label for short-term physical symptoms, such as a racing heart, sweating, and trembling, in situations like public speaking.
For anxiety disorders as a whole, the evidence is thin. A systematic review of propranolol identified only eight qualifying trials and concluded the evidence was insufficient to support routine use for any anxiety disorder. Propranolol may calm your hands before a presentation, but it doesn’t treat the worry underneath. Our guide to propranolol for performance anxiety explains when it fits.
Where Does Therapy Fit?
Cognitive behavioral therapy (CBT) teaches you to notice anxious thought patterns and gradually face what you’ve been avoiding. A large CBT meta-analysis of 41 placebo-controlled trials with 2,843 patients found CBT moderately effective for anxiety-related disorders, with large effects for generalized anxiety disorder and small to moderate effects for panic disorder and social anxiety. The WFSBP guideline calls CBT the first-line psychotherapy for anxiety disorders.
Therapy also helps if you’re coming off a benzodiazepine. The 2025 tapering guideline described below recommends offering psychosocial support alongside a taper to improve the odds of success.
Already Taking Xanax? How to Switch Safely
Please don’t stop on your own. The FDA warns that stopping a benzodiazepine abruptly, or cutting the dose too quickly, can cause withdrawal reactions including seizures, which can be life-threatening. Withdrawal symptoms can appear even with a gradual taper, and the FDA notes some people experience them for months.
In 2025, the American Society of Addiction Medicine and nine other medical organizations published a joint benzodiazepine tapering guideline. Its key recommendations:
- Make tapering a shared decision between you and your prescriber.
- Start with dose reductions of 5% to 10% every 2 to 4 weeks, typically no faster than 25% every 2 weeks.
- People who took lower doses for a shorter time, such as under 3 months, may be able to taper faster.
- Adjust the pace based on how you respond, including pausing if symptoms flare.
Ask your prescriber whether to start a first-line medication, such as an SSRI, before or during the taper so you aren’t left without support. If you have trouble breathing, a seizure, or other serious symptoms, call 911.
This article is for education only and isn’t a substitute for personal medical advice. Never change or stop a medication without talking to your prescriber. It reflects sources available as of October 2026. If you’re having thoughts of suicide, call or text 988.
Talk Through Your Options at Your Own Pace
“When side effects start, you’re on your own until the next appointment.” Switching anxiety medications shouldn’t feel that way. Start your anonymous intake with Siggy to describe your anxiety, what you’ve tried, and the medicines you take now, in your own words. It’s free, asks for no name or email, and gives you a downloadable summary you can share with any clinician. Siggy doesn’t prescribe Xanax or other benzodiazepines. Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including anxiety, and SSRIs are one first-line option. A licensed prescriber reviews your full clinical picture before anything is prescribed. If you’re tapering off Xanax now, keep the prescriber who manages it in the loop.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
What is the closest thing to Xanax that isn't habit-forming?
No non-benzodiazepine medication works the same way Xanax does. Hydroxyzine, an antihistamine, and propranolol, a beta-blocker, are sometimes used for short-term relief, but they work differently and the evidence behind them is more limited. For ongoing anxiety, guidelines recommend SSRIs or SNRIs, which take several weeks to work but aren't habit-forming.
What is the best long-term alternative to Xanax?
SSRIs and SNRIs are the first-line long-term medications for anxiety disorders, according to international treatment guidelines. Cognitive behavioral therapy is the first-line psychotherapy. Many people use both. The right choice depends on your symptoms, history, and other medications, so it's a decision to make with a prescriber.
How long do Xanax alternatives take to work?
SSRIs and other antidepressants usually take 4 to 8 weeks to reach their full effect, according to NIMH, and sleep, appetite, and energy often improve first. Buspirone must be taken every day for 3 to 4 weeks to reach its full effect and doesn't work on an as-needed basis.
Can I stop taking Xanax cold turkey?
No, you shouldn't stop Xanax suddenly if you've been taking it regularly. The FDA warns that stopping a benzodiazepine abruptly or lowering the dose too quickly can cause withdrawal reactions, including seizures, which can be life-threatening. Talk with your prescriber about a gradual, personalized taper.
Is buspirone as effective as Xanax?
Buspirone works for generalized anxiety, but it may be somewhat less effective than benzodiazepines. A Cochrane review of 36 trials found buspirone and related drugs worked better than placebo, with about 4 to 5 people needing treatment for one to benefit. It must be taken daily and isn't habit-forming.
Are Klonopin or Ativan safer alternatives to Xanax?
No, they carry the same dependence risks. Clonazepam (Klonopin) and lorazepam (Ativan) are also benzodiazepines, and the FDA's 2020 boxed warning on abuse, addiction, physical dependence, and withdrawal applies to every drug in the class. Switching to a longer-acting benzodiazepine is sometimes used as a tapering strategy under a prescriber's care.
Sources
- U.S. Food and Drug Administration. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. Drug Safety Communication, September 2020. fda.gov
- Bandelow B, Allgulander C, Baldwin DS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders, version 3. Part I: anxiety disorders. World Journal of Biological Psychiatry. 2023;24(2):79-117. doi:10.1080/15622975.2022.2086295
- National Institute of Mental Health. Mental Health Medications. nimh.nih.gov
- Chessick CA, Allen MH, Thase M, et al. Azapirones for generalized anxiety disorder. Cochrane Database of Systematic Reviews. 2006;(3):CD006115. doi:10.1002/14651858.CD006115
- Guaiana G, Barbui C, Cipriani A. Hydroxyzine for generalised anxiety disorder. Cochrane Database of Systematic Reviews. 2010;(12):CD006815. doi:10.1002/14651858.CD006815.pub2
- Steenen SA, van Wijk AJ, van der Heijden GJ, et al. Propranolol for the treatment of anxiety disorders: systematic review and meta-analysis. Journal of Psychopharmacology. 2016;30(2):128-139. doi:10.1177/0269881115612236
- Carpenter JK, Andrews LA, Witcraft SM, et al. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depression and Anxiety. 2018;35(6):502-514. doi:10.1002/da.22728
- Brunner E, Chen CA, Klein T, et al. Joint clinical practice guideline on benzodiazepine tapering: considerations when risks outweigh benefits. Journal of General Internal Medicine. 2025;40(12):2814-2859. doi:10.1007/s11606-025-09499-2